This topic contains a solution. Click here to go to the answer

Author Question: The nurse explaining epidural anesthesia to a patient would indicate which area as the placement for ... (Read 35 times)

BrownTown3

  • Hero Member
  • *****
  • Posts: 564
The nurse explaining epidural anesthesia to a patient would indicate which area as the placement for this type of anesthesia?
 
  1. A
  2. B
  3. C
  4. D

Question 2

The client is receiving chemotherapy for cancer. The physician has prescribed oprelvekin (Neumega). The nurse has completed medication education and evaluates it as effective when the client makes which statement?
 
  1. This medication will help my chemotherapy work better.
  2. This medication will help increase my platelet count.
  3. This medication will help me regain the weight I have lost.
  4. This medication will help increase my red blood cell count.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sierrahalpin

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

4

Rationale: An epidural is administered above the dura.

Answer to Question 2

2
Rationale 1: Oprelvekin (Neumega) does not enhance the effectiveness of chemotherapy.
Rationale 2: Oprelvekin (Neumega) is used to stimulate the production of platelets in clients who are at risk for thrombocytopenia caused by cancer chemotherapy.
Rationale 3: Oprelvekin (Neumega) does not promote weight gain.
Rationale 4: Oprelvekin (Neumega) does not increase red blood cell count.
Global Rationale: Oprelvekin (Neumega) is used to stimulate the production of platelets in clients who are at risk for thrombocytopenia caused by cancer chemotherapy. Oprelvekin (Neumega) does not enhance the effectiveness of chemotherapy, promote weight gain, or increase red blood cell count.




BrownTown3

  • Member
  • Posts: 564
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


Dnite

  • Member
  • Posts: 297
Reply 3 on: Yesterday
Excellent

 

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library